HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer.
Sci Adv
; 9(11): eadd3243, 2023 03 15.
Article
in En
| MEDLINE
| ID: mdl-36930718
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Histone Deacetylases
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Sci Adv
Year:
2023
Document type:
Article
Country of publication: